Voloridge Investment Management
CBPO

Voloridge Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Voloridge Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-34,421
Closed -$4.08M – 1881
2021
Q1 		$4.08M Buy
34,421
+3,748
+12% +$443K 0.03% 591
2020
Q4 		$3.62M Buy
30,673
+4,046
+15% +$470K 0.03% 542
2020
Q3 		$2.96M Sell
26,627
-4,610
-15% -$495K 0.02% 591
2020
Q2 		$3.19M Buy
31,237
+12,430
+66% +$1.33M 0.04% 472
2020
Q1 		$2.03M Sell
18,807
-7,718
-29% -$887K 0.06% 342
2019
Q4 		$3.09M Buy
26,525
+2,676
+11% +$310K 0.06% 390
2019
Q3 		$2.73M Buy
+23,849
New +$2.37M 0.05% 374

Voloridge Investment Management's CBPO Position: Q2 2021 in Review

Voloridge Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 34,421 shares — an estimated $4.08M sold.

Voloridge Investment Management first reported a position in CBPO in Q3 2019 and held it in 7 quarters. The position peaked at $4.08M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Voloridge Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 34,421 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $4.08M.
  • Voloridge Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2019 and held it in 7 quarters.
  • Voloridge Investment Management's China Biologic Products Holdings, Inc. position peaked at $4.08M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Voloridge Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.